We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00386451
First Posted: October 11, 2006
Last Update Posted: April 27, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Ghent
  Purpose

A prospective randomized study to compare 2 groups:

  • heparine lock with positive pressure
  • lock without a needle with positive pressure

Condition Intervention
Neoplasms Device: Catheter locking systems

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Study Which Compares the Use of a Closing System Without a Needle and With Positive Pressure to a Heparin Lock With Positive Pressure for Patients With a Catheter for Chemotherapy

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Clinical evaluation

Estimated Enrollment: 60
Study Start Date: November 2006
Study Completion Date: July 2007
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Oncological patients who require intravenous chemotherapy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00386451


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Caren Randon, MD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: Caren Randon, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00386451     History of Changes
Other Study ID Numbers: 2006/331
First Submitted: October 10, 2006
First Posted: October 11, 2006
Last Update Posted: April 27, 2009
Last Verified: April 2009

Keywords provided by University Hospital, Ghent:
Intravenous chemotherapy

Additional relevant MeSH terms:
Heparin
Anticoagulants
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action